PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant
Clinical trial NCT03699631 · COMPLETED
Trial details
- NCT number
- NCT03699631
- Sponsor
- Medical College of Wisconsin
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-06
- Primary completion
- 2022-03-02
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.